CTRI/2017/01/007644
尚未招募
4 期
A Pilot Study to Evaluate HCV Therapy in ResourceLimited Settings
Institute of Human Virology University of Maryland0 个研究点目标入组 325 人待定
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Health Condition 1: null- Adults infected with viral hepatitis C or being treated forhepatitis C
- 发起方
- Institute of Human Virology University of Maryland
- 入组人数
- 325
- 状态
- 尚未招募
- 最后更新
- 4年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Be above 18 years old
- •2\. HCV\-infected (naïve/treatment experienced) with HCV RNA \>2000 IU/ml
- •and being evaluated to undergo standard of care treatment,Willing to sign
- •informed consent
排除标准
- •Unable to comply with research study visits
- •2\. Have any condition that the investigator considers a contraindication to
- •study participation
- •3\. Pregnancy of breast feeding.
- •4\. CrCL 30 ml/min by CG equation
- •5\. Patients on concurrent amiodarone therapy
- •6\. Currently on medications as per the prohibited concomitant medication
- •7\. Decompensated cirrhosis
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Open pilot study phase IV to treat co infected HCV-HIV patients after their relapse with interferon therapy.Tratamiento de los pacientes con hepatitis crónica C infectados por el VIH que han recaído trás el tratamiento con terapias basadas en interferón:estudio piloto abierto. - PILOT NRCHRONIC HEPATITIS CEUCTR2005-001192-34-ESVicente Soriano-Hospital Carlos III. Madrid100
已完成
1 期
Phase I/II clinical trials using hepatitis C virus peptide with the combination therapy of interferon and ribavirin for the patient with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000002601Ehime University Graduate School of Medicine, Department of Gastroenterology and Metabology20
已完成
1 期
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.Hepatitis, ChronicHepatitis C VirusNCT00671671Pfizer20
已完成
不适用
Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless AdultsHepatitis C Virus (HCV) InfectionNCT04513899University of California, Irvine10
进行中（未招募）
不适用
randomized study for hcv recurrence treatment in liver transplant patients with ribavirin pre-treatment for 8 weeks follwed by stadard therapy (48 weeks) with interferon pegylated and ribavirin vs standard antivirla therapy with pegylated interferon and ribavirin ofr 48 weeks. - PEARliver tranplanted patients with diagnosis of Hepatitis C recurrenceMedDRA version: 9.1Level: SOCClassification code 10019805EUCTR2010-018870-19-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA